Pharmaceutical

This project involved comprehensive financial reporting, taxation, and financial analysis for a large-scale pharmaceutical distribution company operating across multiple regions with a high volume of products, suppliers, and customers. The work focused on delivering consolidated financial statements, strengthening financial controls, and providing analytical insights to support large-volume operations and strategic planning.

• Assets:
  • Current Assets: Cash and bank balances, trade receivables from hospitals, pharmacies, and distributors, supplier advances, and large-scale pharmaceutical inventory categorized by product groups and warehouses.
  • Non-Current Assets: Warehouses, delivery fleets, cold-chain equipment, IT systems, and office infrastructure.
• Liabilities:
  • Current Liabilities: Trade payables to manufacturers, accrued logistics and warehousing costs, short-term financing, tax payables.
  • Non-Current Liabilities: Long-term borrowings, lease liabilities, and deferred tax balances.
• Equity:
  • Share capital, retained earnings, and reserves.

Purpose:
Presented a consolidated view of the company’s financial position, liquidity, and capital structure, supporting management oversight and external reporting requirements.

• Revenue:
  • High-volume pharmaceutical sales across multiple distribution channels and regions.
• Cost of Sales:
  • Purchase cost of pharmaceutical products, import and freight charges, warehousing, cold-storage handling, and distribution expenses.
• Operating Expenses:
  • Regional distribution costs, administrative salaries, logistics management, compliance expenses, IT and system depreciation.
• Net Profit:
  • Profit before and after tax at both segment and consolidated levels.

Purpose:
Enabled evaluation of operational efficiency, cost structures, and margin performance across large-scale distribution activities.

• Operating Activities:
  • Cash inflows from large customer bases and institutional buyers.
  • Cash outflows for supplier payments, logistics, payroll, and operating costs.
• Investing Activities:
  • Capital expenditure on warehouses, vehicles, cold-chain infrastructure, and technology systems.
• Financing Activities:
  • Bank facilities, loan repayments, interest servicing, and capital funding activities.

Purpose:
Assessed cash sustainability and funding adequacy to support high-volume, continuous distribution operations.

• Recorded movements in retained earnings resulting from operational performance.
• Reflected capital injections, profit allocations, and reserve adjustments.

Purpose:
Provided clarity on equity growth and capital utilization over the reporting period.

• Corporate income tax calculation and filings.
• Compliance with VAT / sales tax, withholding taxes, and payroll obligations across regions.
• Alignment of tax reporting with consolidated financial statements.

Purpose:
Ensured accurate tax reporting while maintaining compliance in a highly regulated, large-scale distribution environment.

• Inventory Performance Analysis:
  • Inventory turnover, stock aging, and warehouse-level inventory efficiency.
• Margin & Pricing Analysis:
  • Product-wise and regional margin evaluation.
• Receivables & Credit Analysis:
  • Assessment of customer credit exposure and collection cycles.
• Working Capital Analysis:
  • Evaluation of inventory, receivables, and payables to support uninterrupted operations.

• Identified cash flow pressure points caused by extended customer credit terms.
• Highlighted inventory concentration risks across warehouses.
• Provided insights on improving supplier payment alignment with customer collections.
• Supported management decisions on pricing, credit policies, and inventory replenishment strategies.

• Consolidated and reliable financial statements supporting management and external stakeholders.
• Improved financial visibility across regions and distribution channels.
• Strengthened control over inventory, margins, and cash flow.
• Structured financial data enabling informed operational and strategic planning.

• Enterprise-level accounting systems and Excel-based analytical models.
• Consolidated reporting templates for multi-location operations.
• Periodic management reports and financial dashboards.

This project covered financial reporting, taxation, and financial analysis for a pharmaceutical products distribution business dealing with high-volume inventory, multiple suppliers, and regulated sales operations. The work focused on delivering accurate financial statements while providing clarity on inventory performance, cash flow, and profitability.

• Assets:
  • Current Assets: Cash and bank balances, trade receivables, advances to suppliers, pharmaceutical inventory categorized by product groups.
  • Non-Current Assets: Office equipment, IT systems, delivery vehicles, and warehouse assets.
• Liabilities:
  • Current Liabilities: Trade payables, accrued expenses, short-term financing, tax liabilities.
  • Non-Current Liabilities: Long-term borrowings and deferred tax balances.
• Equity:
  • Share capital and accumulated retained earnings.

Purpose:
Presented a structured view of the distributor’s financial strength, liquidity, and working capital position, particularly in relation to inventory and receivables.

• Revenue:
  • Sales of pharmaceutical products across multiple distribution channels.
• Cost of Sales:
  • Purchase cost of medicines, freight, warehousing, and handling expenses.
• Operating Expenses:
  • Distribution costs, staff salaries, logistics, administrative expenses, and depreciation.
• Net Profit:
  • Profit before and after tax for the reporting period.

Purpose:
Measured gross margins and operating efficiency, highlighting cost drivers impacting profitability.

• Operating Activities:
  • Cash receipts from customers and payments to suppliers and service providers.
• Investing Activities:
  • Acquisition of vehicles, warehouse equipment, and IT infrastructure.
• Financing Activities:
  • Loan proceeds, repayments, and interest payments.

Purpose:
Analyzed cash movement patterns, ensuring sufficient liquidity to maintain uninterrupted supply operations.

• Reflected movements in retained earnings driven by operating results.
• Captured equity changes resulting from profit allocation and capital adjustments.

Purpose:
Provided transparency on how operational performance translated into equity growth over time.

• Calculation and filing of corporate income tax.
• Compliance with applicable sales tax / VAT, withholding taxes, and payroll obligations.
• Preparation and submission of statutory tax returns and supporting schedules.

Purpose:
Maintained regulatory compliance while ensuring accurate tax reporting aligned with financial records.

• Inventory Analysis:
  • Reviewed inventory levels, turnover ratios, and slow-moving items.
• Margin Analysis:
  • Evaluated product-wise and channel-wise profitability.
• Receivables Analysis:
  • Assessed customer payment patterns and credit exposure.
• Working Capital Review:
  • Analyzed the balance between inventory, receivables, and payables.

• Identified inventory holding risks affecting cash flow.
• Highlighted margin variations across product categories.
• Provided guidance on aligning supplier payment terms with customer collections.
• Supported decision-making on inventory replenishment and pricing strategies.

• Clear and reliable financial statements for management review.
• Improved visibility into inventory performance and cash flow.
• Strengthened financial control across distribution operations.
• Structured financial data supporting operational and strategic decisions.

• Accounting software and Excel-based financial models.
• Customized reports for inventory and margin analysis.
• Periodic financial summaries for management review.